Molbio Diagnostics Limited (NSE:MOLBIO)
India · Delayed Price · Currency is INR 1,320.10
-15.90 (-1.19%)
Nov 11, 2026, 1:00 PM IST
Molbio Diagnostics Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Molbio Diagnostics stock has a consensus rating of "Strong Buy" and an average price target of ₹1,705. The average 1-year stock price forecast is 29.16% higher than the current stock price, while the lowest is ₹1,600 (+21.20%) and the highest is ₹1,800 (+36.35%).
Price Target: ₹1,705 (+29.16%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Oct 7, 2026.
Analyst Ratings
The average analyst rating for Molbio Diagnostics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|
| Strong Buy | 1 | 2 | 2 |
| Buy | 0 | 1 | 1 |
| Hold | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 |
| Total | 1 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Motilal Oswal No rating | Motilal Oswal | Buy Maintains ₹1,800 | Buy | Maintains | ₹1,800 | +36.35% | Oct 7, 2026 |
Financial Forecast
Revenue This Year
17.95B
from 14.46B
Increased by 24.16%
Revenue Next Year
22.38B
from 17.95B
Increased by 24.71%
EPS This Year
22.44
EPS Next Year
35.34
from 22.44
Increased by 57.50%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.